Price $142.29 |
Market Cap
38.15B
|
Sector Health Care |
Div. Growth
7.90%
|
|
P/E
32.3
|
P/B
7.83
|
P/S
6.14
|
Dividend %
0.60%
|
|
P/CF
-
|
P/FCF
50.2
|
Op. Cash Flow
1.31M
|
FCF
2.6
|
|
Op. Margin
22.50%
|
Net Margin
19.40%
|
ROE
24.50%
|
ROI
14.70%
|
|
ROA
12.00%
|
EPS Growth
39.20%
|
Current Ratio
2.2
|
Debt/Equity
50.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Clearside Biomedical Inc (CLSD) | $1.50 | - | - | 99.2M | Strong Buy |
| Lineage Cell Therapeutics Inc (LCTX) | $1.47 | - | - | 285.1M | Strong Buy |
| Biomerica Inc (BMRA) | $3.20 | - | - | 33.9M | Strong Buy |
| AngioDynamics, Inc. (ANGO) | $23.90 | - | - | 881.1M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $2.81 | - | - | 31.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
